Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
hepatitis B
Pharma
Gilead's once-rejected hepatitis D med wins FDA nod
More than three years after Gilead's hepatitis D drug was rebuffed by the FDA on manufacturing concerns, the treatment has redeemed itself.
Fraiser Kansteiner
May 26, 2026 9:49am
Sanofi bolsters adult vaccine roster with $2.2B Dynavax purchase
Dec 29, 2025 10:24am
Fierce Healthcare
Medical groups decry CDC's major child vaccine change
Dec 17, 2025 2:00pm
ACIP revokes universal hep B vaccine endorsement for newborns
Dec 5, 2025 2:43pm
CDC's ACIP again delays vote on newborn hepatitis B vaccines
Dec 4, 2025 4:41pm
ACIP to meet with new chair as former leader gets HHS promotion
Dec 2, 2025 10:20am